Purpose: In hypoxic tumoral tissues, vascular endothelial growth factor (VEGF) expression is positively regulated by histone deacetylase 1 (HDAC1) and negatively regulated by the tumour suppressor protein von Hippel-Lindau (VHL) via hypoxia induced factor-1 alpha (HIF-1alpha). It has been reported that VEGF, HDAC1 and LL-37, but not VHL, are over-expressed in psoriatic skin. Although HIF-1alpha is constitutively expressed in normal keratinocytes, it is not known if HDAC1 and VHL can regulate VEGF production in these cells.
Angiogenesis is a complex process for the formation of new blood vessels from pre-existing vessels in tissues. is process is essential for healing wounds, but angiogenesis also plays an important role in the exacerbation of some diseases, such as cancer, arthritis and psoriasis. e angiogenic process can be triggered by several molecules produced by epithelial cells, -broblasts, endothelial cells and tumoral cells, and vascular endothelial growth factor (VEGF) is the principal proangiogenic factor released by these cells. [1] In hypoxic tumoral cells, hypoxia induced factor 1 (HIF-1) is the main transcription factor involved in the expression of VEGF; [2] histone deacetylase 1 (HDAC1) [3] and the tumour suppressor protein von Hippel-Lindau (VHL) [4] regulate the levels of the HIF-1alpha subunit in the cellular cytoplasm. In keratinocytes, factors such as transforming growth factor-alpha (TGF-alpha), epidermal growth factor, and insulin-like growth factor I and II(IGF-I/II) are involved in the induction of VEGF production. [5] Although HIF-1alpha is constitutively expressed in normal keratinocytes, [6] [7] it is not known if HDAC1 and VHL can regulate the levels of HIF-1alpha in keratinocytes to alter VEGF production.
HIF-1 is a heterodimeric transcription factor activated by hypoxia, and it is composed of the HIF-1alpha and HIF-1beta subunits. [8] e HIF-1beta subunit is expressed constitutively, but the HIF-1alpha subunit is regulated based on oxygen conditions. In normoxic conditions, HIF-1alpha is hydroxylated at the proline residues 402 and/or 564 by prolyl hydroxylases (PHD) [9] [10] and is acetylated at lysine-532 by the ARD1 acetyltransferase. [11] In normoxic conditions, the tumour suppressor protein von Hippel-Lindau (VHL) is also expressed; VHL forms a complex with Elongin-C, which in turn, then recruits Elongin-B and other subunits. is complex conduces the ubiquitination of acetylated and hydroxylated HIF1alpha to be degraded in the proteasome, which leads to the downregulation of VEGF. [12] e lack of VHL is associated with a variety of tumours, including haemangioblastomas of the retina and tumours of the central nervous system. [13] [14] In hypoxic endothelial cells, VHL is downregulated by histone deacetylases (HDACs). [3] e HDACs are expressed ubiquitously, are localised predominantly in the nucleus, and display high enzymatic activity towards histone substrates. [15] e global inhibition of HDAC activity inhibits angiogenesis and tumour growth by reducing the expression of proangiogenic factors. [16] [17] [18] In particular, the levels of HDAC1 are increased in hypoxic conditions, which leads to the decrease of VHL and p53, allowing an accumulation of HIF-1alpha and an increase in VEGF production in human endothelial cells. [3] e porcine cathelicidin, PR39, is another molecule with angiogenic activity. PR39 inhibits proteosome activity, avoiding HIF-1alpha degradation. [19] Human cathelicidin LL-37 augments VEGF mRNA expression in HaCaT cells [20] .
In the psoriatic-skin lesions, HDAC1, HIF-1alpha, LL-37 and VEGF, but not VHL, are upregulated, [21] which suggests that these molecules are involved in psoriatic angiogenesis. It is well known that keratinocytes produce VEGF in psoriatic lesions; however, the regulation of VEGF expression in these cells is poorly understood. In this study, HaCaT cells were transfected with the cDNA coding sequences of HDAC1, LL-37 and VHL to observe the participation of these molecules in the regulation of VEGF expression.
Materials and Methods

Cloning
Gene-speci c primers were used for RT-PCR to amplify the DNA coding sequences of the HDAC1 and LL-37 of HaCaT cells and the VHL of healthy skin biopsies. [21] Cloning was performed using the pcDNA3.1-TOPO vector (Invitrogen, Carlsbad CA, USA).
e generated plasmids were named pHDAC1, pLL-37 and pVHL, which contained the genes hdac1, ll37 and vhl, respectively.
Transfection assays
HaCaT cells were cultured in DMEM medium supplemented with 5% fetal bovine serum (FBS) (Gibco, Rockville, MD, USA) in 6-well plates until 80% con uence was reached. e cells were transfected with the pHDAC1, pLL-37 and pVHL plasmids using Lipofectamine 2000 (Invitrogen) as per by the supplier's directions. Supernatants were obtained from cellular cultures and were stored at -70°C until use. Transfected cells were treated with Trizol (Invitrogen) to extract RNA for mRNA expression analysis. To transfect HaCaT cells for the small interference RNA (siRNA) assays, 250, 500 and 1000 ng/mL of HDAC1-siRNA, 1000 ng/mL of HIF-1alpha-siRNA or 500 ng/mL of control siRNA (c-siRNA; Santa Cruz, Santa Cruz CA, USA) were used. pVHL-transfected HaCaT cells were cultured in the presence of 10 mM cobalt chloride to generate hypoxia-mimetic conditions, and the amount of VEGF was evaluated in the supernatant.
RNA isolation and RT-PCR analysis
Total RNA extraction was performed with TRIzol (Invitrogen). For the Reverse Transcriptase (RT) reaction, total RNA (3 μg) with 0.5 µg of oligo-(dT)15-18 (Invitrogen) was dena-tured at 70°C for 10 min. e master mix was prepared with 1X single strand bu er, 0.5 mM DTT, 500 µM of each dNTP (Invitrogen) and 200U of MMLV reverse transcriptase (Invitrogen). e RT reactions were performed at 42°C for 1 h. e PCR reactions were performed using 1U of Taq DNA polymerase (Invitrogen), 1µl cDNA, 1X bu er, 1 mM MgCl2, 200 µM of each dNTP and 0.2 µM of each corresponding speci c primer. [21] e optimal PCR conditions were 30 cycles of 30 s at 92°C, 30 s at 60°C and 30 s at 72°C.
Inhibition of HDAC1 activity in HaCaT cells with Trichostatin A (TSA)
HaCaT cells were cultured in 6-well plates with supplemented DMEM until they reached 85% con uence. e cells were treated with 30, 90, 150, 240 or 480 ng/mL of TSA dissolved in ethanol (Sigma, St. Louis, MO, USA) for 24 hours to inhibit the HDAC1 activity. e supernatants were kept to measure VEGF production by ELISA.
ELISA
ELISA was performed to quantify the amount of VEGF (Human VEGF CytoSetTM kit, Invitrogen BioSource) in the supernatants of transfected and non-transfected cells. Brie y, polystyrene wells were coated with anti-human VEGF monoclonal antibody diluted in carbonate bu er and incubated at 4°C overnight. e wells were blocked with 3% fat-free milk, then 100 µL of the supernatant of transfected cultures was added to each well and incubated for 1 hour. A er washing, the wells were incubated with the biotin-conjugated rabbit anti-human-VEGF secondary antibody. Streptavidinconjugated peroxidase was used to develop the colour with H2O2 and o-phenylenediamine as the substrates. Absorbance was measured at 492 nm.
Immuno uorescence analysis
HaCaT cells were cultured on cover slides. e cells were xed with cold absolute methanol for 10 minutes and washed with TBS. e cover slides were treated with blocking solution (bovine serum albumin 3%) for 1 hour. e cells were rst incubated with an HIF-1alpha-, VEGF-, VHL-speci c antibody or rabbit IgG as control (Santa Cruz) for 1 hour at 37°C. Goat anti-Rabbit IgG FITC-conjugated (Invitrogen) secondary antibodies were used to observe the expression of the proteins by uorescence microscopy.
Western blot analysis.
HaCaT cells transfected with pHDAC1 and pcDNA3.1 were lysed and cytoplasmic and nuclear proteins were obtained using a nuclear extraction kit (IMGENEX Corporation; San Diego CA, USA) according with the supplier. In both extracts HIF-1alpha was analyzed using anti-HIF-1alpha antibody.
Results
HDAC1 positively regulates VEGF expression in HaCaT cells.
To analyse if HDAC1 regulates VEGF expression in HaCaT cells, cells were transfected with pHDAC1. e cells transfected with pHDAC1 expressed higher levels of HDAC1 mRNA compared with cells transfected with the empty vector pcDNA3.1-TOPO (Fig. 1a) . When VEGF production was analysed in the supernatants of the pHDAC1-transfected HaCaT cells, an over-production of VEGF was detected in a timedependent manner. e highest VEGF production occurred at 72 hours post-transfection, but the over-production of VEGF was abolished in HaCat cells co-transfected with HIF-1alpha-siRNA and pHDAC1 (p<0.05; Fig. 1b ). High levels of VEGF were detected by immuno uorescence analysis in the cytoplasms of the pHDAC1-transfected HaCaT cells at 72 hours post-transfection (Fig. 1c) . To corroborate the role that HDAC1 plays in VEGF expression, trichostatin A (TSA) and HDAC1-siRNA were used to inhibit the activity of HDACs.
HaCaT cells treated with TSA showed a decrease in VEGF production in a dose-dependent manner (p<0.05; Fig. 1d ). e HaCaT cells treated with HDAC1 siRNA (250-1000 nM) showed lower levels of HDAC1 mRNA than the cells treated with c-siRNA (Fig.1e) . As expected, and as seen in TSAtreated cells, HDAC1-siRNA-transfected HaCaT cells produced low quantities of VEGF, when compared with levels seen in c-siRNA-treated cells (p<0.05; Fig. 1f ). ese results indicate that HDAC1 positively regulates VEGF expression in keratinocytes.
e expression of VHL decreases VEGF production in HaCaT cells
e pVHL-transfected HaCaT cells showed higher levels of VHL mRNA expression than those transfected with the control vector (Fig. 2a) . Analysing the expression of VHL by immuno uorescence, a high level of VHL expression was detected in the cytoplasm of the pVHL-transfected cells and the expression of VHL was seldom observed in the control cells (Fig. 2b) . When the production of VEGF was analysed in the supernatants of pVHL-transfected HaCaT cells, the levels of VEGF decreased in a time-dependant manner. A er 72 hours post-transfection, the production of VEGF was reduced approximately ve fold; however, this decrease in VEGF production was not observed in pVHL-transfected HaCaT cells cultured in hypoxia-mimetic conditions (Fig. 2c) . To con rm the decrease of VEGF in the VHL-transfected HaCaT cells, intracellular VEGF was assayed by immuno uorescence, and it was found to be decreased in the cytoplasm (Fig. 2d) . ese results demonstrate that VEGF expression is negatively regulated by VHL in keratinocytes.
LL-37 increases the production of VEGF in HaCaT cells
High levels of VEGF were found in the supernatants of LL-37-transfected HaCaT cells, and this increase from control levels occurred in a time-dependent manner (Fig. 3) . ese results suggest that LL-37 can positively regulate the expression of VEGF in keratinocytes. 
Co-participation of HDAC1, LL-37 and VHL in the regulation of VEGF production in HaCaT cells
Co-transfection assays were performed in HaCaT cells to analyse how VEGF production is a ected when HDAC1, LL-37 and VHL interact. To study the e ect of VHL on HDAC1 activity in VEGF production, HaCaT cells were co-transfected with a constant amount of pHDAC1 (0.4 μg) and with di erent quantities of pVHL (0.1 to 1.6 μg). VEGF production decreased as pVHL was augmented, overcoming the inductive activity of HDAC1 (p<0.05; Fig. 4a ). When the reverse analysis was performed using a constant quantity of pVHL and a variable amount of pHDAC1, a recovery in the production of VEGF was observed as HDAC1 was augmented (p<0.05; Fig.  4b ). ese results show that HDAC1 and VHL have opposite e ects on the production of VEGF in keratinocytes. e e ect of LL-37 on HDAC1 activity in VEGF production was also studied. HaCaT cells, co-transfected with a constant amount of pHDAC1 (0.4μg) and variable amounts of pLL-37, showed an increase in VEGF expression as pLL-37 was increased (p<0.05; Fig. 4c ). Similar results were obtained when the cells were co-transfected with a constant amount of pLL-37 and di erent amounts of pHDAC1 (p<0.05; Fig. 4d) .
ese results suggest that both molecules have a positive e ect on the regulation of VEGF expression in keratinocytes. e positive e ect of LL-37 was also observed in co-transfected cells with constant amounts of pVHL and increasing amounts of pLL-37: the production of VEGF was recovered as LL-37 was augmented with a constant expression of VHL (Fig. 4e) . However, the opposite e ect was observed in the cells cotransfected with constant amounts of pLL-37 and variable pVHL: the expression of VEGF decreased as VHL was augmented (p<0.05; Fig. 4f ) . ese results show that LL-37 has a positive e ect on VEGF expression and that VHL has the opposite e ect of LL-37 and HDAC1 in keratinocytes.
E ect of the overexpression of HDAC1, LL-37 and VHL on the cytoplasmic levels of HIF-1alpha in HaCaT cells
e expression and localisation of HIF-1alpha in HDAC1-, LL-37-and VHL-transfected HaCaT cells was studied. Nontransfected cells and pcDNA3.1-transfected HaCaT cells have a basal expression of HIF-1alpha in the cytoplasm (Fig. 5a) . In pHDAC1-transfected HaCaT cells, the translocation of HIF1alpha into the nucleus was visualised by immuno uorescence and then veri ed through western blot analysis (Fig. 5a and 5b,  respectively) . In pLL-37-transfected HaCaT cells, there were increased levels of HIF-1alpha in the cytoplasm. Low levels of HIF-1alpha were detected in the cytoplasm of pVHLtransfected HaCaT cells (Fig. 5a ).
Discussion
HDACs have been related with angiogenesis and hyperproliferation processes because tumour cells treated with HDAC inhibitors, such as TSA [22] and suberoylanilide hydroxamic acid (SAHA), [23] disrupted these processes. [15] In this study, in keratinocytes treated with TSA and with HDAC1-siRNA, the VEGF production was found to decrease, suggesting that HDAC1 plays an important role in the production of VEGF in keratinocytes.
It is known that HDAC1 regulates the expression of VHL; for instance, human endothelial cells transfected with HDAC1 have a low expression of VHL. [3] is study demonstrated that HDAC1 can act as an antagonist of the VHLrelated e ect on VEGF production when HaCaT cells were cotransfected with pHDAC1 and pVHL. is study also showed that when keratinocytes were transfected with HDAC1, HIF1alpha was translocated into the nucleus and the production of VEGF was upregulated; the knockdown of HIF1-alpha de- creased the production of VEGF (Fig. 5a ). is result suggests that HDAC-1 regulates VEGF production via HIF-1alpha. e antagonistic e ect of HDAC1 on VHL might occur in keratinocytes because acetylated-HIF-1alpha, an HDAC1 substrate, shows low a nity to VHL when deacetylated. [24] In breast cancer cell lines, the deacetylation of HIF-1alpha is mediated by the nucleosome remodelling histone deacetylation (NuRD) complex. [25] is complex is composed of HDAC1 or HDAC2 and the metastasis-associated protein 1 (MTA1). MTA1, [26] HDAC1 and HDAC2 [27] [28] are expressed in human epidermis and HaCaT cells. us, the NuRD complex could be deacetylating HIF-1alpha to avoid its degradation via VHL in pHDAC1-transfected HaCaT cells, leading to the accumulation of VEGF in the cell.
It has been well established in tumour cells that under normoxic conditions, VHL protein is part of the ubiquitin E3 ligase complex that ubiquitinates the hydroxylated-HIF-1alpha and that ubiquitinated HIF-1apha is susceptible to proteasomal degradation. One consequence of low levels of HIF-1alpha is the decrease of VEGF production. [12] In this work, the production of VEGF was also observed to be negatively controlled by the activity of VHL in keratinocytes (Fig. 2) . ese data are consistent with observations in psoriatic skin biopsies (highly vascularised tissues) because the absence of the VHL expression and the presence of HDAC1 [21] could explain the high production of VEGF. Additionally, mice with a vhl-/-epidermal deletion show an increase in erythropoietin and in skin vascularisation; [13] vhl-/-keratinocytes over-express HIF1alpha and HIF-2alpha, [4] which causes the increase of the expression of HIF target genes such as VEGF, PGK, GLUT1, INOS mRNAs and erythropoietin. [29] Studying the opposite biological phenomenon in keratinocytes, the upregulation of VHL decreased the basal levels of HIF-1alpha in the cytoplasm and decreased VEGF production (Fig. 5a) ; in hypoxicmimetic cells transfected with pVHL, which produce high levels of HIF-1apha, VEGF production was not decreased. ese results suggest that, as in tumour tissues, VHL negatively regulates VEGF expression via HIF-1alpha in keratinocytes.
Recently, LL-37-tranfected keratinocytes were seen to produce high quantities of mRNA of VEGF [20] and peptidoglycan from Staphylococcus aureus was seen to induces the production of LL-37 and VEGF in this cell type. [30] While evaluating keratinocytes for the regulatory activity of LL-37 on VEGF production, LL-37 and HDAC1 were observed to increase HIF-1alpha and VEGF expression in transfected cells.
ese results suggest that LL-37 could have an important role in the angiogenesis of psoriasis. In psoriatic lesions, this peptide is highly expressed with other molecules associated with proangiogenic activity, such as HIF-1apha and HDAC1. [21] LL-37 has recently been suggested to be a possible trigger in the etiopathogenesis of psoriasis. Lande et al. reported that stressed keratinocytes release DNA that forms complexes with the LL-37, which, in turn, activates plasmacytoid dendritic cells (pDCs) to produce interferon-alpha (IFNalpha) [31] . Dermal DCs activated by IFN-alpha (produced by pDCs) lead to the production of 1 and 17 cytokines, which, in turn, induce the proliferation of keratinocytes. [31] It has recently has been reported that the HIF-1apha and HDAC-1 system may play an important role in T-cell di erentiation to 17 in psoriasis patients. [32] [33] ese results, when combined with what occurs in psoriatic lesions, suggest that the hyperproliferation of keratinocytes leads to hypoxic conditions. [29] [34] [30] In this environment, psoriatic keratinocytes produce high quantities of VEGF via HIF-1alpha that is not ubiquitinated by VHL due to the intervention of HDAC1 and LL-37. e same phenomenon could be occurring in squamous cell carcinoma (SCC) as HDAC1 overexpression has been observed in this cancer [35] and because in oral squamous cell cancinoma, VEGF is over-expressed and is reg ulate d by H I F-1a lpha under hyp oxic conditions. [36] [37] In the same way, the dysfunction of VHL is also associated with the development of tongue cancer [39] as well as in psoriasis. [21] us, new compounds that inhibit the activity of HDAC1 and LL-37 or that activate VHL could be used as targets for the control of the angiogenesis of psoriasis.
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